Trials / Sponsors / Syros Pharmaceuticals
Syros Pharmaceuticals
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia Acute Promyelocytic Leukemia | Phase 1 | 2021-09-17 |
| Terminated | Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 2 | 2021-08-26 |
| Terminated | Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic S Myelodysplastic Syndromes | Phase 3 | 2021-02-08 |
| Completed | A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer | Phase 1 | 2020-01-23 |
| Terminated | A Study of SY-1365 in Adult Patients With Advanced Solid Tumors Advanced Solid Tumors, Ovarian Cancer, Breast Cancer | Phase 1 | 2017-05-12 |
| Completed | A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or My Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | 2016-09-20 |